In vivo Studies on Pharmacokinetics, Toxicity and Immunogenicity of Polyelectrolyte Nanocapsules Functionalized with Two Different Polymers: Poly-L-Glutamic Acid or PEG

• Published in: International journal of nanomedicine Vol. 14; pp. 9587 - 9602
• Main Authors: Karabasz, Alicja, Szczepanowicz, Krzysztof, Cierniak, Agnieszka, Mezyk-Kopec, Renata, Dyduch, Grzegorz, Szczęch, Marta, Bereta, Joanna, Bzowska, Monika
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.12.2019; Dove; Dove Medical Press
• Subjects: Amino acids; Analysis; animal studies; Animals; Antibodies; Antigen-antibody reactions; Copolymers; Criminal investigation; Cytokines - blood; DNA; Drug Delivery Systems; Enzyme-linked immunosorbent assay; Female; Fluorescence; Genetic research; Glutamate; Glycols (Class of compounds); Immune response; Immune system; Lysine; Mice, Inbred BALB C; Nanocapsules - chemistry; Nanocapsules - toxicity; Organ Specificity - drug effects; Original Research; polyelectrolyte nanocapsules; Polyelectrolytes - chemistry; Polyelectrolytes - pharmacokinetics; Polyelectrolytes - toxicity; Polyethylene glycol; Polyethylene Glycols - chemistry; Polyethylene Glycols - pharmacokinetics; Polyethylene Glycols - toxicity; Polyglutamic Acid - chemistry; Polyglutamic Acid - pharmacokinetics; Polyglutamic Acid - toxicity; Polymers; Polyols; Rhodamines - chemistry; stealth polymers; Tissue Distribution; Toxicity; Up-Regulation - drug effects; Poland; stealth polymers; polyelectrolyte nanocapsules; animal studies
• ISSN: 1178-2013; 1176-9114; 1178-2013
• DOI: 10.2147/IJN.S230865

The functionalization of a nanoparticle surface with PEG (polyethylene glycol) is an approach most often used for extending nanomaterial circulation time, enhancing its delivery and retention in the target tissues, and decreasing systemic toxicity of nanocarriers and their cargos. However, because PEGylated nanomedicines were reported to induce immune response including production of anti-PEG antibodies, activation of the complement system as well as hypersensitivity reactions, hydrophilic polymers other than PEG are gaining interest as its replacement in nanomaterial functionalization. Here, we present the results of in vivo evaluation of polyelectrolyte nanocapsules with biodegradable, polyelectrolyte multilayer shells consisting of poly-l-lysine (PLL) and poly-l-glutamic (PGA) acid as a potential drug delivery system. We compared the effects of nanocapsules functionalized with two different "stealth" polymers as the external layer of tested nanocapsules was composed of PGA (PGA-terminated nanocapsules, NC-PGA) or the copolymer of poly-l-lysine and polyethylene glycol (PEG-terminated nanocapsules, NC-PEG). Nanocapsules pharmacokinetics, biodistribution and routes of eliminations were analysed postmortem by fluorescence intensity measurement. Toxicity of intravenously injected nanocapsules was evaluated with analyses of blood morphology and biochemistry and by histological tissue analysis. DNA integrity was determined by comet assay, cytokine profiling was performed using flow cytometer and detection of antibodies specific to PEG was performed by ELISA assay. We found that NC-PGA and NC-PEG had similar pharmacokinetic and biodistribution profiles and both were eliminated by hepatobiliary and renal clearance. Biochemical and histopathological evaluation of long-term toxicity performed after a single as well as repeated intravenous injections of nanomaterials demonstrated that neither NC-PGA nor NC-PEG had any acute or chronic hemato-, hepato- or nephrotoxic effects. In contrast to NC-PGA, repeated administration of NC-PEG resulted in prolonged increased serum levels of a number of cytokines. Our results indicate that NC-PEG may cause undesirable activation of the immune system. Therefore, PGA compares favorably with PEG in equipping nanomaterials with stealth properties. Our research points to the importance of a thorough assessment of the potential influence of nanomaterials on the immune system.